Effective Management of IBS-D and Hepatic Encephalopathy
REEFAXIN-550 is specifically formulated to address complex gastrointestinal and liver-related disorders. It is widely prescribed for the treatment of Irritable Bowel Syndrome with Diarrhea (IBS-D), where it helps reduce common symptoms such as abdominal pain, bloating, and stool urgency. Additionally, it plays a critical role in liver care by preventing the recurrence of Hepatic Encephalopathy, a condition where the liver fails to filter toxins, leading to brain dysfunction.
Targeted Antimicrobial Action with Minimal Side Effects
The active ingredient, Rifaximin, works by inhibiting bacterial RNA synthesis, effectively stopping the growth of harmful, ammonia-producing bacteria in the gut. Because less than 1% of the medication is absorbed systemically, REEFAXIN-550 delivers its full therapeutic force directly to the intestines. This localized action significantly reduces the risk of systemic side effects typically associated with traditional antibiotics, providing a safer profile for long-term management.
Premium Quality and Reliable Packaging
Produced by MK Healthcare, an ISO-GMP Certified pharmaceutical company, REEFAXIN-550 meets the highest standards of purity and efficacy. The tablets are presented in Alu-Alu packaging (10x10 Tablets), ensuring maximum protection against moisture and oxidation to maintain the drug's stability. This professional-grade packaging is designed to provide patients and healthcare providers with a dependable product from one of India's leading pharmaceutical manufacturers.
Trusted Choice for PCD Pharma Franchise and Third-Party Manufacturing
REEFAXIN-550 is a high-demand product within the Gastro and Antibiotics range. Backed by extensive manufacturing expertise in Chandigarh and Himachal, MK Healthcare offers this formulation for PCD Pharma Franchise and third-party manufacturing opportunities. It is a vital addition to any healthcare portfolio focused on providing advanced, science-backed solutions for infectious diarrhea, SIBO (Small Intestinal Bacterial Overgrowth), and chronic liver health support.
